Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.

ZVRA
Zevra Therapeutics, Inc.US flagNASDAQ Global Select
12.45
USD
+0.42
- -
735.98MMarket Cap

Zevra Therapeutics, Inc. (ZVRA) Stock Split History

Learn about Zevra Therapeutics, Inc.'s most recent 1-for-16 basis stock split on December 28, 2020. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Zevra Therapeutics, Inc.'s most recent stock split

Split Date: 2020-12-28
Split Ratio: 1:16
Price Before Split: $0.90
Price After Split: $0.06

Developer API

Get ZVRA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ZVRA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 16.00 times fewer shares (a 1:16 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Zevra Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-12-281:16Yes$0.90$0.06

About Zevra Therapeutics, Inc.

Company overview and industry information

Zevra Therapeutics, Inc. (ZVRA) operates in the Biotechnology industry. The recent 1-for-16 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Zevra Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.